SCHEMBL8515319

SCHEMBL8515319

Cc1cc(=O)oc2cc(CC(N)=O)ccc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA9 Q16790 4/20 0.62
▸ CA1 P00915 3/20 0.62
▸ CA2 P00918 1/20 0.62
▸ CA5A P35218 1/20 0.62
▸ ALDH1A1 P00352 10/20 0.57
▸ KDM4E B2RXH2 9/20 0.57
▸ HPGD P15428 8/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.57
▸ TDP1 Q9NUW8 2/20 0.57
▸ GLA P06280 6/20 0.56
▸ HSD17B10 Q99714 6/20 0.56
▸ GAA P10253 5/20 0.56
▸ CA12 O43570 3/20 0.56
▸ CASP1 P29466 3/20 0.56
▸ CASP7 P55210 3/20 0.56
▸ LMNA P02545 1/20 0.56
▸ CYP1A2 P05177 1/20 0.56
▸ CYP2C9 P11712 1/20 0.56
▸ AKR1B1 P15121 1/20 0.56
▸ UGT1A1 P22309 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30767880 0.87 CA9 (0.59) CA9CA1CA2CA5AALDH1A1
SCHEMBL3250182 0.87 CA9 (0.59) CA9CA1CA2CA5AALDH1A1
SCHEMBL17358708 0.81 CA9 (0.64) CA9CA1CA2CA5AALDH1A1
SCHEMBL8388797 0.80 CA9 (0.66) CA9CA1CA2CA5AALDH1A1
SCHEMBL4929370 0.79 CA9 (0.61) CA9CA1CA2CA5AALDH1A1
SCHEMBL11180486 0.78 CA9 (0.64) CA9CA1CA2CA5AALDH1A1
SCHEMBL4609492 0.78 KDM4E (0.61) CA9CA1CA2CA5AALDH1A1
SCHEMBL3245747 0.78 CA9 (0.56) CA9CA1CA2CA5AALDH1A1
SCHEMBL483004 0.77 KDM4E (0.61) CA9CA1CA2CA5AALDH1A1
SCHEMBL29403594 0.77 KDM4E (0.61) CA9CA1CA2CA5AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012070024-A1 CARBONIC ANHYDRASE INHIBITORS WITH ANTIMETASTATIC ACTIVITY METASIGNAL THERAPEUTICS INC. (CA) 2012-05-31 — — WO disclosed
Send feedback